Business Context and Reporting Period
This Form 8-K is a current report filed by Nephros, Inc. on March 26, 2021. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol NEPH. The report addresses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel change and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the resignation of a director:
- Malcolm Persen notified the Company of his intention to resign from the Board of Directors.
- The resignation is effective no later than August 2021, with a specific date to be determined.
- The Company explicitly states the resignation is not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, financial outlook, or management commentary regarding future business performance. No risks, contingencies, or unusual items are disclosed in this specific report.
Key Facts for Investor Verification
- Verify the exact resignation date of Malcolm Persen once determined by the Company.
- Confirm whether the Board has initiated a search for a replacement director.
- Review subsequent filings to ensure no undisclosed disagreements arise related to this departure.